AMY SHAVER: Open Payments
NPI 1134545239 · NORTH CHESTERFIELD, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,040 in 90 payments from 34 companies in 2025. Trend: 2023 $2,368 · 2024 $1,798 · 2025 $2,040
Food & beverage: $2,040
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 13 | $266 |
| AstraZeneca Pharmaceuticals LP | 8 | $211 |
| Janssen Biotech, Inc. | 12 | $174 |
| PFIZER INC. | 6 | $125 |
| Amgen Inc. | 1 | $117 |
| Legend Biotech USA Inc. | 4 | $92 |
| Incyte Corporation | 4 | $82 |
| Ipsen Biopharmaceuticals, Inc | 3 | $80 |
| BeOne Medicines USA, Inc. | 3 | $79 |
| Caris MPI, Inc. | 3 | $60 |
Products named: CARVYKTI, KYPROLIS, PLUVICTO, KISQALI, IBRANCE, Onivyde, LYNPARZA, MI CANCER SEEK.
Industry payments across VA — which companies pay providers there.
